⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AB News
AllianceBernstein Holding, L.P.
AB Announces December 31, 2025 Assets Under Management
prnewswire.com
AB
AB CarVal Grows Commercial Real Estate Private Credit Capabilities Through Multifamily and Residential Lending Partnerships
prnewswire.com
AB
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
globenewswire.com
AB
AllianceBernstein announces Onur Erzan as President
prnewswire.com
AB
EQH
AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
globenewswire.com
AB
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
globenewswire.com
AB
AllianceBernstein: Why Data Centers May Help Drive ESG-Labeled Bond Issuance
accessnewswire.com
AB
AllianceBernstein Launches AB US Equity ETF (XCHG) on the New York Stock Exchange
prnewswire.com
AB
AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function
globenewswire.com
AB
AB Announces November 30, 2025 Assets Under Management
prnewswire.com
AB